Iridex director buys 9,080 and 20,920 company shares of stock

Q: What insider activity did Iridex Corp (IRIX) report in this Form 4?

A director of Iridex Corp (IRIX) reported buying company common stock, with two separate purchase transactions on December 11, 2025 and December 12, 2025.

Q: How many Iridex (IRIX) shares did the director purchase?

The director purchased 9,080 shares of Iridex common stock on December 11, 2025 and 20,920 shares on December 12, 2025.

Q: At what prices were the IRIX shares purchased by the director?

On December 11, 2025, shares were bought at a weighted average price between $0.9508 and $0.97. On December 12, 2025, shares were bought at a weighted average price between $0.9205 and $0.97.

Q: What indirect Iridex (IRIX) shareholdings are reported for the director?

The filing reports 69,300 shares held indirectly through the director’s spouse and 30,026 shares held indirectly through the William M. Moore Trust and the Patricia A. Moore Trust as tenants in common.

Q: What is the director’s relationship to Iridex Corp (IRIX)?

The reporting person is identified as a Director of Iridex Corp, filing individually as one reporting person.

Iridex Corp director reported buying additional company common stock in December 2025.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Iridex Corp director reported buying additional company common stock in December 2025. On December 11, 2025, the director purchased 9,080 shares at a weighted average price between $0.9508 and $0.97. On December 12, 2025, the director purchased a further 20,920 shares at a weighted average price between $0.9205 and $0.97, bringing direct beneficial ownership to 280,674 shares of Iridex common stock.

The report also discloses indirect holdings of 69,300 shares held by the director’s spouse and 30,026 shares held through the William M. Moore Trust and the Patricia A. Moore Trust as tenants in common.

Insider Trade Summary

Net Buyer: 30,000 shares

Net Buy 4 txns

Insider MOORE WILLIAM M

Role Director

Bought 30,000 shs ($0.00)

Type	Security	Shares	Price	Value
Purchase	Common Stock	20,920	$0.00	$0.00
Purchase	Common Stock	9,080	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 280,674 shares (Direct); Common Stock — 69,300 shares (Indirect, By Spouse); Common Stock — 30,026 shares (Indirect, See Footnote)

Footnotes (3)

F1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9508 to $0.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
F2. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9205 to $0.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
F3. The shares are held by William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Iridex Corp (IRIX) report in this Form 4?

A director of Iridex Corp (IRIX) reported buying company common stock, with two separate purchase transactions on December 11, 2025 and December 12, 2025.

How many Iridex (IRIX) shares did the director purchase?

The director purchased 9,080 shares of Iridex common stock on December 11, 2025 and 20,920 shares on December 12, 2025.

At what prices were the IRIX shares purchased by the director?

On December 11, 2025, shares were bought at a weighted average price between $0.9508 and $0.97. On December 12, 2025, shares were bought at a weighted average price between $0.9205 and $0.97.

How many Iridex shares does the director own after these transactions?

Following the reported transactions, the director beneficially owns 280,674 shares of Iridex common stock directly.

What indirect Iridex (IRIX) shareholdings are reported for the director?

The filing reports 69,300 shares held indirectly through the director’s spouse and 30,026 shares held indirectly through the William M. Moore Trust and the Patricia A. Moore Trust as tenants in common.

What is the director’s relationship to Iridex Corp (IRIX)?

The reporting person is identified as a Director of Iridex Corp, filing individually as one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 12/15/2025 - 11:58 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOORE WILLIAM M

(Last)

(First)

(Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW

94043

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/11/2025		P		9,080	A	⁽¹⁾	259,754	D
Common Stock	12/12/2025		P		20,920	A	⁽²⁾	280,674	D
Common Stock								69,300	I	By Spouse
Common Stock								30,026	I	See Footnote⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9508 to $0.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

2. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9205 to $0.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

3. The shares are held by William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common.

	/s/ Nilo De Castro, Attorney-in-fact for William M. Moore	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR